'Not too late to review cost' of breast cancer drug Kadcyla

The NHS has rejected a drug that can extend lives of women with breast cancer because it is ‘too expensive’. Jennifer Cozzone head of Health Economics and Pricing at Roche and Mia Rosenblatt from Breast Cancer Campaign discuss.

Release date:


5 minutes

This clip is from

Featured in...